Cargando...
Organ responses with daratumumab therapy in previously treated AL amyloidosis
Immunoglobulin light chain amyloidosis (AL amyloidosis) involves deposition of abnormally folded light chains into a wide range of tissues causing organ dysfunction, including in the heart and kidney. Daratumumab, a CD38-targeted antibody, has recently demonstrated efficacy in producing hematologic...
Gardado en:
| Publicado en: | Blood Adv |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society of Hematology
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7013253/ https://ncbi.nlm.nih.gov/pubmed/32027745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000776 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|